Lipoprotein(a) as a risk factor for maternal cardiovascular disease mortality in kindreds with familial combined hyperlipidemia or familial hypertriglyceridemia

Clinical Genetics

Volumn 60, Issue 3, 2001, Pages 188-197

  Kim, H ^a   Marcovina, S M ^a   Edwards, K L ^a   McKnight, B ^a   Bradley, C M ^a   McNeely, M J ^b   Psaty, B M ^c   Motulsky, A G ^a   Austin, M A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Seattle Children's Hospital   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Hyperlipidemic families; Lipoprotein(a); Parental history

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A; LIPOPROTEIN A;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLASSIFICATION; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; EPIDEMIOLOGY; EVALUATION; FAMILIAL HYPERLIPEMIA; FAMILY HISTORY; FATHER; FEMALE; GENETICS; HIGH RISK PATIENT; HUMAN; HYPERTRIGLYCERIDEMIA; LINEAR SYSTEM; LIPOPROTEIN BLOOD LEVEL; MALE; MATERNAL DISEASE; MATERNAL MORTALITY; MORTALITY; PARENT; PRIORITY JOURNAL; PROGENY; REGRESSION ANALYSIS; RISK FACTOR; STANDARD;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; FAMILY HEALTH; FATHERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERTRIGLYCERIDEMIA; KRINGLES; LINEAR MODELS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MOTHERS; PEDIGREE; POLYMORPHISM, GENETIC; RISK FACTORS; TIME FACTORS;

EID: 0034779036     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2001.600304.x     Document Type: Article

References (64)

1. A new serum type system in man - The Lp system
2. The mysteries of lipoprotein(a)
3. Pathophysiological implication of the structural domains of lipoprotein(a)
4. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study
5. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants
6. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study
7. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men
8. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: Results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS)
9. Lipoprotein(a) levels and risk of coronary heart disease in men
10. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men
11. Lipoprotein (a) and coronary heart disease: A prospective case-control study in a general population sample of middle aged men
12. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
13. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies
14. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study
15. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study
16. A prospective study of lipoprotein(a) and the risk of myocardial infarction
17. Lipoprotein (a) and coronary heart disease risk: A nested case-control study of the Helsinki Heart Study participants
18. Lipoprotein(a) as a determinant of coronary heart disease in young women
19. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women
20. Lipoprotein(a) as a risk factor for coronary artery disease
21. Potential environmental effects on adult lipoprotein(a) levels: Results from Swedish twins
22. Lipoprotein(a): Relation to other risk factors and genetic heritability. Results from a Dutch parent-twin study
23. Lipoprotein(a) in women twins: Heritability and relationship to apolipoprotein(a) phenotypes
24. Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus
25. The apolipoprotein (a) gene: A transcribed hypervariable locus controlling plasma lipoprotein (a) concentration
26. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations
27. The relationship between infant and parent Lp(a) levels
28. Correlation of toddlers' serum lipoprotein(a) concentration with parental values and grandparents' coronary heart disease: The STRIP baby study
29. Lipoprotein Lp(a). A risk factor for myocardial infarction
30. Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children
31. Lipoprotein (a) concentrations as risk indicators for atherosclerosis
32. Relation of lipoprotein(a) in 11- to 19-year-old adolescents to parental cardiovascular heart disease
33. High lipoprotein(a) in children from kindreds with parental premature myocardial infarction
34. Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents
35. Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease
36. Lipoprotein(a) in childhood: Relation with other atherosclerosis risk factors and family history of atherosclerosis
37. Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives
38. Lipoprotein(a) in Korean children and a history of coronary or cerebral vascular events in their older family members
39. Coronary risk factors in school children in relation to their family history of coronary heart disease and hyperlipidemia
40. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans
41. Familial lipoprotein disorders in patients with premature coronary artery disease
42. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
43. Myocardial infarction in the familial forms of hypertriglyceridemia
44. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study
45. Pleiotropic genetic effects on LDL size, plasma triglyceride, and HDL cholesterol in families
46. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a)
47. Identification of 34 apolipoprotein(a) isoforms: Differential expression of apolipoprotein(a) alleles between American blacks and whites
48. Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: Basis for a standardized isoform nomenclature
49. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women
50. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
51. The Behavior of Maximum Likelihood Estimates under Non-standard Conditions
52. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
53. Maximum likelihood estimation of misspecified models
54. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity
55. Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged males
56. Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease
57. Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction
58. Expressed hyper-variable polymorphism of apolipoprotein (a)
59. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma
60. Plasma triglycerides and lipoprotein(a): Inverse relationship in a hyperlipidemic Italian population
61. Effect of hypertriglyceridaemia on lipoprotein (a) serum concentrations
62. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause